Ajay Kumar Gopal

Ajay Gopal practices at Fred Hutchinson Cancer Center in Seattle, Washington, part of Fred Hutchinson Cancer Center.

Ajay Gopal's NPI, 1194801902, was assigned on October 27, 2006. Ajay Gopal graduated from Emory School of Medicine in 1993. Ajay Gopal holds Washington license MD00034592.

Ajay Gopal's primary practice is Fred Hutchinson Cancer Center, at 825 Eastlake Avenue East, Seattle, WA 98109.

Ajay Gopal's primary practice is Fred Hutchinson Cancer Center in Seattle, Washington, part of Fred Hutchinson Cancer Center. Ajay Gopal is also affiliated with UW Medical Center - Montlake. The medical group on file is UW Physicians. Dmand AI also links Ajay Gopal to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Ajay Gopal practices, 3 sites in all. Vendor and product names are available with a free account.

Medical oncology is Ajay Gopal's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Ajay Gopal is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Ajay Gopal's licenses on file in 2 states: Washington and North Carolina.

Dmand AI lists chronic leukemia, immune deficiency disease and lymphoma among the conditions Ajay Gopal treats.

CMS data shows 206 Medicare services from Ajay Gopal across 3 procedure codes in 2024, for 70 Medicare patients. Medicare paid $11,554 for them. Every service was in an office.

CMS counts 70 Medicare patients who saw Ajay Gopal in 2024. The largest group is 65 to 74, with 42 patients. 70% of them have high cholesterol, and 54% have high blood pressure. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Ajay Gopal's median patient age at 69, with 42% women.

In 2024, Ajay Gopal wrote 77 Medicare Part D claims for 21 patients. 57% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $201,343 in total drug cost. In 2023, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Ajay Gopal for performance year 2024, reported through an alternative payment model (APM). Ajay Gopal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Ajay Gopal as offering telehealth.

Dmand AI links 301 papers to Ajay Gopal, published from 2003 to 2025. 2020 was the busiest year, with 21. The most frequent topics are Hematopoietic Stem Cell Transplantation, Antineoplastic Combined Chemotherapy Protocols and Antibodies, Monoclonal. Ajay Gopal has published most often in Blood. Ajay Gopal's most frequent co-authors are Damian J. Green, MD, Brian Gerald Till, MD and Mazyar Shadman, MD, MPH.

Dmand AI links Ajay Gopal to 23 clinical trials, 12 of them phase 2 studies. 5 are still active or recruiting. Conditions studied include Hodgkin Disease, Lymphoma and Intraocular Lymphoma. Fred Hutchinson Cancer Center sponsors the most, 8.

CMS Open Payments shows 138 general payments to Ajay Gopal from 24 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 82% of the total. Kite Pharma, Inc. paid the most, $30,986. It also lists 4 research payments totaling $11,725 from 2018 to 2022.

Dmand AI lists 1 award for Ajay Gopal, most recently Regional Top Doctor in 2014.

Ajay Gopal graduated from Emory School of Medicine in 1993. Ajay Gopal is a member of ASCO and ASH.

Ajay Gopal is in network with 10 carriers, including Aetna, Elevance and Humana. HMO plans come from the most carriers, 6. Check the plan with the practice before a visit.